Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prediction

  • You have access
    Review of the Role of Radiomics in Tumour Risk Classification and Prognosis of Cancer
    YEO LI WEN and MICHELLE LEECH
    Anticancer Research July 2020, 40 (7) 3605-3618; DOI: https://doi.org/10.21873/anticanres.14350
  • You have access
    Development of Normal Tissue Complication Probability Model for Trismus in Head and Neck Cancer Patients Treated With Radiotherapy: The Role of Dosimetric and Clinical Factors
    MASAHIRO MORIMOTO, HENK P. BIJL, ARJEN VAN DER SCHAAF, CHENG-JIAN XU, ROEL J.H.M. STEENBAKKERS, OLGA CHOUVALOVA, YASUO YOSHIOKA, TERUKI TESHIMA and JOHANNES A. LANGENDIJK
    Anticancer Research December 2019, 39 (12) 6787-6798; DOI: https://doi.org/10.21873/anticanres.13894
  • You have access
    Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response
    JULIA KOVACOVA, JAROSLAV JURACEK, ALEXANDR POPRACH, TOMAS BUCHLER, JINDRICH KOPECKY, ONDREJ FIALA, MAREK SVOBODA and ONDREJ SLABY
    Anticancer Research May 2018, 38 (5) 2961-2965;
  • You have access
    Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer
    DIRK RADES, LIESA DZIGGEL, THEO VENINGA, AMIRA BAJROVIC and STEVEN E. SCHILD
    Anticancer Research September 2016, 36 (9) 4817-4819;
  • You have access
    Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
    ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH and TOMAS BUCHLER
    Anticancer Research May 2016, 36 (5) 2459-2465;
  • You have access
    Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
    IVAN TRÁVNÍČEK, JINDŘICH BRANŽOVSKÝ, KRISTÝNA KALUSOVÁ, ONDŘEJ HES, LUBOŠ HOLUBEC, KEVIN BAULETH PELE, TOMÁŠ ÜRGE and MILAN HORA
    Anticancer Research October 2015, 35 (10) 5661-5666;
  • You have access
    Utility of Measuring Circulating Tumor Cell Counts to Assess the Efficacy of Treatment for Carcinomas of Unknown Primary Origin
    KEIGO KOMINE, MASAHIRO INOUE, KAZUNORI OTSUKA, KOJI FUKUDA, HIROSHI NANJO and HIROYUKI SHIBATA
    Anticancer Research June 2014, 34 (6) 3165-3168;
  • You have access
    Predictive Role of CEA and CYFRA 21-1 in Patients with Advanced-stage NSCLC Treated with Erlotinib
    ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, MAREK MINARIK, ZBYNEK BORTLICEK and ONDREJ TOPOLCAN
    Anticancer Research June 2014, 34 (6) 3205-3210;
  • You have access
    Progression-free Survival Is Accurately Predicted in Patients Treated with Chemotherapy for Epithelial Ovarian Cancer by the Histoculture Drug Response Assay in a Prospective Correlative Clinical Trial at a Single Institution
    PHILL-SEUNG JUNG, DAE-YEON KIM, MOON-BO KIM, SHIN-WHA LEE, JONG-HYEOK KIM, YONG-MAN KIM, YOUNG-TAK KIM, ROBERT M. HOFFMAN and JOO-HYUN NAM
    Anticancer Research March 2013, 33 (3) 1029-1034;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire